{
    "nctId": "NCT02132000",
    "briefTitle": "Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients",
    "officialTitle": "N/A",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Patients in Premenopausal, Estrogen and/or Progesterone Receptor Positive",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2, PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 3036,
    "primaryOutcomeMeasure": "survival outcomes: disease free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Clinical diagnosis of Breast cancer\n* Received standard treatment (chemotherapy, operation, or radiotherapy)\n* premenopausal\n* estrogen and/or progesterone receptor positive\n\nExclusion Criteria:\n\n* Metastatic tumors\n* During pregnancy or lactation",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}